Systemic and mucosal protective immunity to pneumococcal surface protein A

Annals of the New York Academy of Sciences

Volumn 797, Issue , 1996, Pages 118-126

  Briles, David E ^a,b,c   Tart, Rebecca Creech ^a   Wu, Hong Yin ^a   Ralph, Beth A ^a   Russell, Michael W ^a,d   McDaniel, Larry S ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; CROSS REACTING ANTIGEN; MEMBRANE ANTIGEN; PROTEIN A; STREPTOCOCCUS ANTIGEN;

BACTERIAL IMMUNITY; CONFERENCE PAPER; IMMUNOGENICITY; INTRANASAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; RESPIRATORY TRACT MUCOSA; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0030476831     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb52954.x     Document Type: Conference Paper

References (42)

1. FRASER, D. W. 1982. What are our bacterial disease problems? In Bacterial Vaccines. J. B. Bobbins, J. C. Hill & J. C. Sadoff, Eds. Thieme-Stratton. New York.
2. ANONYMOUS. 1991. Centers for Disease Control HIV/AIDS Surveillance Report.
3. GREENWOOD, B. M., A. M. GREENWOOD, A. K. BRADLEY, S. TULLOCH, R. HAYES & F. S. J. OLDFIELD. 1987. Deaths in infancy and early childhood in a well vaccinated, rural, West African population. Ann. Trop. Pediatr. 7: 91.
4. SPIKA, J. S., M. H. MUNSHI, B. WOJTYANIAK, D. A. SACK, A. HOSSAIN, M. RAHMAN & S. K. SAHA. 1989. Acute lower respiratory infections: A major cause of death in children in Bangladesh. Ann. Trop. Pediatr. 9: 33.
5. BALE, J. R. 1990. Etiology and epidemiology of acute respiratory tract infections in children in developing countries. Rev. Infect. Dis. 12 (Suppl 8): S861.
6. BERMAN, S. & K. MCINTOSH. 1985. Selective primary health care: Strategies for control of disease in the developing world. XXI acute respiratory infections. Rev. Infect. Dis. 7: 647.
7. KLUGMAN, K. P. 1990. Pneumococcal resistance to antibiotics. Clin. Microbiol. Rev. 3: 171.
8. MARTON, A., M. GULYAS, R. MUNOZ & A. TOMASZ. 1991. Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. J. Infect. Dis. 163: 542.
9. MUNOZ, R., J. M. MUSSER, M. CRAIN, D. E. BRILES, A. MARTON, A. J. PARKINSON, U. SORENSEN & A. TOMASZ. 1992. Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: Characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis. Clin. Infect. Dis. 15: 112.
10. HENDLEY, J. O., M. A. SANDE, P. M. STEWART & J. GWALTNEY, JR. 1975. Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J. Infect. Dis. 132: 55.
11. GRAY, B. M., G. M. CONVERSE, III & H. C. DILLON. 1980. Epidemiologic studies of Streptococcus pneumonias in infants: Acquisition, carriage, and infection during the first 24 months of life. J. Infect. Dis. 142: 923.
12. KLEIN, J. O. 1981. The epidemiology of pneumococcal diseases in infants and children. Rev. Infect. Dis. 3: 246.
13. BOHR, V., N. RASMUSSEN, B. HANSEN, A. GADE, H. KJERSEM, N. JOHSEN & O. PAULSON. 1985. Pneumococcal meningitis: An evaluation of prognostic factors in 164 cases based on mortality and on a study of lasting sequelae. J. Infect. Dis. 10: 143.
14. BOLAN, G., C. V. BROOME, R. R. FACKLAM, B. D. PLIKAYTIS, W. D. FRASER & W. F. I. SCHLECH. 1986. Pneumococcal vaccine efficacy in selected populations in the United States. Ann. Intern. Med. 104: 1.
15. SHAPIRO, E. D., A. T. BERG, R. AUSTRIAN, D. SCHROEDER, V. PARCELLS, A. MARGOLIS, R. K. ADAIR & J. D. CLEMMENS. 1991. Protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N. Engl. J. Med. 325: 1453.
16. GOTSCHLICH, E. C., I. GOLDSCHNEIDER, M. L. LEPOW & R. GOLD. 1977. The immune response to bacterial polysaccharides in man. In Antibodies in Human Diagnosis and Therapy. E. Haber & R. M. Krause, Eds. :391. Raven Press. New York.
17. COWAN, M. J., A. J. AMMANN, D. W. WARA, V. M. HOWIE, L. SCHULTZ, N. DOYLE & M. KAPLAN. 1978. Pneumococcal polysaccharide immunization in infants and children. Pediatrics 62: 721.
18. BARBOUR, M. L., R. T. MAYON-WHITE, D. W. CROOK, C. COLES & E. R. MOXON. 1993. The influence of Haemophilus influenzae type b (Hib) conjugate vaccine (PRP-T) on oropharyngeal carriage of Hib in infants under 12 months of age. ICAAC Abstr. 33: 175.
19. CHIU, S. S., P. D. GREENBERG, S. M. MARCY, V. K. WONG, S. J. CHANG, C. Y. CHIU & J. I. WARD. 1994. Mucosal antibody responses in infants following immunization with Haemophilia influenzae. Pediatr. Res. Abstr. 35: 10.
20. DOUGLAS, R. M., H. D. H. B. MILES & J. C. PATON. 1986. Pneumococcal carriage and type-specific antibody: Failure of a 14-valent vaccine to reduce carriage in healthy children. Am. J. Dis. Child. 140: 1183.
21. DOUGLAS, R. M. & H. B. MILES. 1984. Vaccination against Streptococcus pneumoniae in childhood: Lack of demonstrable benefit in young Australian children. J. Infect. Dis. 149: 861.
22. MCDANIEL, L. S., J. S. SHEFFIELD, P. DELUCCHI & D. E. BRILES. 1991. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type. Infect. Immun. 59: 222.
23. BRILES, D. E., C. FORMAN, J. C. HOROWITZ, J. E. VOLANAKIS, W. H. BENJAMIN, JR., L. S. MCDANIEL, J. ELDRIDGE & J. BROOKS. 1989. Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens. Infect. Immun. 57: 1457.
24. BRILES, D. E., J. D. KING, M. A. GRAY, L. S. MCDANIEL, E. SWIATLO & K. A. BENTON. 1996. PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice. Vaccine 14: 858-867.
25. MCDANIEL, L. S., J. YOTHER, M. VIJAYAKUMAR, L. MCGARRY, W. R. GUILD & D. E. BRILES. 1987. Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA). J. Exp. Med. 165: 381.
26. BRILES, D. E., J. YOTHER & L. S. MCDANIEL. 1988. Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae. Rev. Infect. Dis. 10: S372.
27. VAN DIJK, H. Unpublished observations.
28. YOTHER, J. & D. E. BRILES. 1992. Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis. J. Bacteriol. 174: 601.
29. WALTMAN, W. D., II, L. S. MCDANIEL, B. M. GRAY & D. E. BRILES. 1990. Variation in the molecular weight of PspA (pneumococcal surface protein A) among Streptococcus pneumoniae. Microb. Pathog. 8: 61.
30. MCDANIEL, L. S., G. SCOTT, K. WIDENHOFER, J. M. CARROLL & D. E. BRILES. 1986. Analysis of a surface protein of Streptococcus pneumonias recognized by protective monoclonal antibodies. Microb. Pathog. 1: 5.
31. GRAY, B. M. 1995. Pneumococcal infections in an era of multiple antibiotic resistance. Adv. Pediatr. Infect. Dis. 11: 55.
32. YOTHER, J. & J. M. WHITE. 1994. Novel surface attachment mechanism for the Streptococcus pneumoniae protein PspA. J. Bacteriol. 176: 2976.
33. MCDANIEL, L. S., B. A. RALPH, D. O. MCDANIEL & D. E. BRILES. 1994. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260. Microb. Pathog. 17: 323.
34. CRAIN, M. J., W. D. WALTMAN, II, J. S. TURNER, J. YOTHER, D. E. TALKINGTON, L. M. MCDANIEL, B. M. GRAY & D. E. BRILES. 1990. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae. Infect. Immun. 58: 3293.
35. RALPH, B. A., D. E. BRILES & L. S. MCDANIEL. 1996. A cross-reactive, protection-eliciting, region is present between amino acids 192 and 299 of PspA of Streptococcus pneumoniae. Manuscript in preparation.
36. AMSBAUGH, D. F., C. T. HANSEN, B. PRESCOTT, P. W. STASHAK, D. R. BARTHOLD & P. J. BAKER. 1972. Genetic control of the antibody response to type III pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness. J. Exp. Med. 136: 931.
37. BRILES, D. E., M. NAHM, K. SCHROER, J. DAVIE, P. BAKER, J. KEARNEY & R. BARLETTA. 1981. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 Streptococcus pneumoniae. J. Exp. Med. 153: 694.
38. MCDANIEL, L. S., G. SCOTT, J. F. KEARNEY & D. E. BRILES. 1984. Monoclonal antibodies against protease sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. J. Exp. Med. 160: 386.
39. TALKINGTON, D. F., D. L. CRIMMINS, D. C. VOELLINGER, J. YOTHER & D. E. BRILES. 1991. A 43-kilodalton pneumococcal surface protein, PspA isolation, protective abilities, and structural analysis of the amino-terminal sequence. Infect. Immun. 59: 1285.
40. WU, H.-Y., A. VIROLAINEN, J. KING, M. RUSSELL & D. E. BRILES. 1996. A model of pneumococcal carriage in adult mice. Manuscript in preparation.
41. CONVERSE, G. M., III & H. C. DILLON, JR. 1977. Epidemiological studies of Streptococcus pneumoniae in infants: Methods of isolating pneumococci. J. Clin. Microbiol. 5: 293.
42. WU, H.-Y., M. NAHM, Y. GUO, M. W. RUSSELL & D. E. BRILES. 1996. Intranasal immunization can prevent carriage and infection with Streptococcus pneumoniae. J. Infect. Dis. Submitted.